Rank | Gene Set | Z-score |
---|---|---|
1 | glucuronate metabolic process (GO:0019585) | 6.65643582 |
2 | uronic acid metabolic process (GO:0006063) | 6.65643582 |
3 | cellular glucuronidation (GO:0052695) | 6.51239781 |
4 | L-phenylalanine catabolic process (GO:0006559) | 6.49970825 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.49970825 |
6 | L-phenylalanine metabolic process (GO:0006558) | 6.27450580 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.27450580 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 5.93963610 |
9 | response to nitrosative stress (GO:0051409) | 5.90858521 |
10 | sulfur amino acid catabolic process (GO:0000098) | 5.77152255 |
11 | xenobiotic catabolic process (GO:0042178) | 5.72868394 |
12 | glyoxylate metabolic process (GO:0046487) | 5.53010022 |
13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.51981643 |
14 | indole-containing compound catabolic process (GO:0042436) | 5.50944821 |
15 | indolalkylamine catabolic process (GO:0046218) | 5.50944821 |
16 | tryptophan catabolic process (GO:0006569) | 5.50944821 |
17 | bile acid biosynthetic process (GO:0006699) | 5.33158734 |
18 | kynurenine metabolic process (GO:0070189) | 5.33056674 |
19 | cysteine metabolic process (GO:0006534) | 5.19835872 |
20 | tryptophan metabolic process (GO:0006568) | 5.18313927 |
21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.09965125 |
22 | urea cycle (GO:0000050) | 4.96218947 |
23 | urea metabolic process (GO:0019627) | 4.96218947 |
24 | alpha-linolenic acid metabolic process (GO:0036109) | 4.89251667 |
25 | benzene-containing compound metabolic process (GO:0042537) | 4.86937364 |
26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.85898959 |
27 | regulation of cholesterol esterification (GO:0010872) | 4.76390665 |
28 | aldehyde catabolic process (GO:0046185) | 4.64497063 |
29 | regulation of fibrinolysis (GO:0051917) | 4.61208367 |
30 | amino-acid betaine metabolic process (GO:0006577) | 4.58671989 |
31 | nitrogen cycle metabolic process (GO:0071941) | 4.58512446 |
32 | bile acid metabolic process (GO:0008206) | 4.57929532 |
33 | serine family amino acid catabolic process (GO:0009071) | 4.54078841 |
34 | negative regulation of fibrinolysis (GO:0051918) | 4.50793810 |
35 | lysine metabolic process (GO:0006553) | 4.49784004 |
36 | lysine catabolic process (GO:0006554) | 4.49784004 |
37 | protein carboxylation (GO:0018214) | 4.49669576 |
38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.49669576 |
39 | reverse cholesterol transport (GO:0043691) | 4.47046542 |
40 | complement activation, alternative pathway (GO:0006957) | 4.44063448 |
41 | ethanol oxidation (GO:0006069) | 4.43722947 |
42 | regulation of protein activation cascade (GO:2000257) | 4.42957681 |
43 | cytidine metabolic process (GO:0046087) | 4.42580118 |
44 | cytidine catabolic process (GO:0006216) | 4.42580118 |
45 | cytidine deamination (GO:0009972) | 4.42580118 |
46 | homocysteine metabolic process (GO:0050667) | 4.39379861 |
47 | regulation of triglyceride catabolic process (GO:0010896) | 4.37216432 |
48 | phospholipid efflux (GO:0033700) | 4.33618543 |
49 | aromatic amino acid family metabolic process (GO:0009072) | 4.31715356 |
50 | flavonoid metabolic process (GO:0009812) | 4.28185756 |
51 | protein-lipid complex remodeling (GO:0034368) | 4.27797413 |
52 | macromolecular complex remodeling (GO:0034367) | 4.27797413 |
53 | plasma lipoprotein particle remodeling (GO:0034369) | 4.27797413 |
54 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.15581570 |
55 | regulation of complement activation (GO:0030449) | 4.14591621 |
56 | drug catabolic process (GO:0042737) | 4.08564588 |
57 | tyrosine metabolic process (GO:0006570) | 4.07773474 |
58 | alpha-amino acid catabolic process (GO:1901606) | 4.05618474 |
59 | triglyceride homeostasis (GO:0070328) | 4.01267149 |
60 | acylglycerol homeostasis (GO:0055090) | 4.01267149 |
61 | bile acid and bile salt transport (GO:0015721) | 3.99058011 |
62 | negative regulation of sterol transport (GO:0032372) | 3.98978298 |
63 | negative regulation of cholesterol transport (GO:0032375) | 3.98978298 |
64 | L-ascorbic acid metabolic process (GO:0019852) | 3.89588686 |
65 | cellular biogenic amine catabolic process (GO:0042402) | 3.89331317 |
66 | amine catabolic process (GO:0009310) | 3.89331317 |
67 | cellular amino acid catabolic process (GO:0009063) | 3.88889339 |
68 | cholesterol efflux (GO:0033344) | 3.87017455 |
69 | cellular ketone body metabolic process (GO:0046950) | 3.86737971 |
70 | indolalkylamine metabolic process (GO:0006586) | 3.84740567 |
71 | protein-lipid complex assembly (GO:0065005) | 3.84418493 |
72 | serine family amino acid metabolic process (GO:0009069) | 3.83278712 |
73 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.80859881 |
74 | regulation of bile acid biosynthetic process (GO:0070857) | 3.80602454 |
75 | phospholipid homeostasis (GO:0055091) | 3.80263879 |
76 | regulation of cholesterol metabolic process (GO:0090181) | 3.78694362 |
77 | imidazole-containing compound metabolic process (GO:0052803) | 3.76335115 |
78 | cellular modified amino acid catabolic process (GO:0042219) | 3.74308303 |
79 | negative regulation of lipase activity (GO:0060192) | 3.74276988 |
80 | plasma lipoprotein particle clearance (GO:0034381) | 3.72749841 |
81 | glycine metabolic process (GO:0006544) | 3.72233773 |
82 | eosinophil chemotaxis (GO:0048245) | 3.70994897 |
83 | low-density lipoprotein particle remodeling (GO:0034374) | 3.69943413 |
84 | carnitine metabolic process (GO:0009437) | 3.68159086 |
85 | DNA deamination (GO:0045006) | 3.67950651 |
86 | carboxylic acid catabolic process (GO:0046395) | 3.63031869 |
87 | organic acid catabolic process (GO:0016054) | 3.63031869 |
88 | plasma lipoprotein particle assembly (GO:0034377) | 3.62608291 |
89 | glutamate metabolic process (GO:0006536) | 3.60495078 |
90 | glutathione derivative biosynthetic process (GO:1901687) | 3.59991322 |
91 | glutathione derivative metabolic process (GO:1901685) | 3.59991322 |
92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.58438996 |
93 | fatty acid oxidation (GO:0019395) | 3.58367780 |
94 | regulation of cholesterol homeostasis (GO:2000188) | 3.58311589 |
95 | coenzyme catabolic process (GO:0009109) | 3.57716800 |
96 | drug transmembrane transport (GO:0006855) | 3.57631465 |
97 | monocarboxylic acid catabolic process (GO:0072329) | 3.57573932 |
98 | fatty acid beta-oxidation (GO:0006635) | 3.52490084 |
99 | serine family amino acid biosynthetic process (GO:0009070) | 3.52182989 |
100 | lipid oxidation (GO:0034440) | 3.51482963 |
101 | short-chain fatty acid metabolic process (GO:0046459) | 3.51328964 |
102 | plasma lipoprotein particle organization (GO:0071827) | 3.50291963 |
103 | drug metabolic process (GO:0017144) | 3.46801422 |
104 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.45853223 |
105 | arginine metabolic process (GO:0006525) | 3.45465658 |
106 | cholesterol homeostasis (GO:0042632) | 3.44822569 |
107 | intestinal cholesterol absorption (GO:0030299) | 3.44549606 |
108 | phenylpropanoid metabolic process (GO:0009698) | 3.43879048 |
109 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.43181681 |
110 | glycosphingolipid catabolic process (GO:0046479) | 3.42978301 |
111 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.37000554 |
112 | protein-lipid complex subunit organization (GO:0071825) | 3.29779440 |
113 | eosinophil migration (GO:0072677) | 3.27089907 |
114 | regulation of cholesterol storage (GO:0010885) | 3.21942723 |
115 | glycolipid catabolic process (GO:0019377) | 3.12307499 |
116 | response to interferon-beta (GO:0035456) | 3.04231154 |
117 | oligosaccharide catabolic process (GO:0009313) | 3.00152936 |
118 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.96877790 |
119 | lipoprotein metabolic process (GO:0042157) | 2.96700929 |
120 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.96085023 |
121 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.93058954 |
122 | regulation of mononuclear cell migration (GO:0071675) | 2.92438368 |
123 | ceramide catabolic process (GO:0046514) | 2.92182999 |
124 | neutrophil activation involved in immune response (GO:0002283) | 2.90287497 |
125 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.88933587 |
126 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.87809237 |
127 | regulation of T cell tolerance induction (GO:0002664) | 2.86453768 |
128 | positive regulation of defense response to virus by host (GO:0002230) | 2.85843431 |
129 | cellular response to interleukin-15 (GO:0071350) | 2.85633622 |
130 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.81373931 |
131 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.81168872 |
132 | response to interleukin-15 (GO:0070672) | 2.81030877 |
133 | immunoglobulin mediated immune response (GO:0016064) | 2.80824026 |
134 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.80743674 |
135 | cellular response to interferon-beta (GO:0035458) | 2.79898506 |
136 | lipoprotein transport (GO:0042953) | 2.79440344 |
137 | cholesterol transport (GO:0030301) | 2.76450294 |
138 | sterol transport (GO:0015918) | 2.76450294 |
139 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.72508450 |
140 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.69398413 |
141 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.67121176 |
142 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.66217459 |
143 | intestinal absorption (GO:0050892) | 2.62629898 |
144 | negative regulation of interleukin-12 production (GO:0032695) | 2.61332667 |
145 | angiotensin maturation (GO:0002003) | 2.58887178 |
146 | regulation of macrophage chemotaxis (GO:0010758) | 2.57763877 |
147 | regulation of superoxide anion generation (GO:0032928) | 2.54219859 |
148 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.53391105 |
149 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.52078598 |
150 | response to thyroid hormone (GO:0097066) | 2.50770512 |
151 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.50760514 |
152 | regulation of regulatory T cell differentiation (GO:0045589) | 2.49512376 |
153 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.49164941 |
154 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.49164941 |
155 | regulation of activation of Janus kinase activity (GO:0010533) | 2.49112622 |
156 | heme transport (GO:0015886) | 2.48222897 |
157 | regulation of vitamin metabolic process (GO:0030656) | 2.47190593 |
158 | epoxygenase P450 pathway (GO:0019373) | 2.45694652 |
159 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.43393276 |
160 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.42247488 |
161 | N-acetylneuraminate metabolic process (GO:0006054) | 2.42112740 |
162 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.41862803 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.67781022 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.69551742 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.44749144 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.04969001 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.01627011 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.74995588 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.55184946 |
8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.10671789 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.74426771 |
10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.72417113 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.64035956 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.10031775 |
13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.97475990 |
14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.87100160 |
15 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.46465067 |
16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.42510433 |
17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.35853981 |
18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.12287022 |
19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.11614102 |
20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03027203 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.01552447 |
22 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8062531 |
23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.95819146 |
24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.94756743 |
25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.93261550 |
26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92150673 |
27 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.90901353 |
28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.90166069 |
29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.88497371 |
30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86026381 |
31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.84501584 |
32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77893565 |
33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76232752 |
34 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.70130412 |
35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69232290 |
36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.66385579 |
37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.64213930 |
38 | * MYB_26560356_Chip-Seq_TH2_Human | 1.63495341 |
39 | GATA3_26560356_Chip-Seq_TH2_Human | 1.59692665 |
40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.55775877 |
41 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47572460 |
42 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.44735582 |
43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43628455 |
44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42421482 |
45 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42188863 |
46 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41990612 |
47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41886425 |
48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41309058 |
49 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.39447865 |
50 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.38064917 |
51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37118747 |
52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36273336 |
53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35502090 |
54 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33824170 |
55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33566621 |
56 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.32253273 |
57 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31833889 |
58 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.30513608 |
59 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.29142004 |
60 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.24668948 |
61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24086251 |
62 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23817666 |
63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22237972 |
64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19320067 |
65 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18931133 |
66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18542590 |
67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18379391 |
68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18115432 |
69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17339844 |
70 | * MYB_26560356_Chip-Seq_TH1_Human | 1.17199376 |
71 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.16680180 |
72 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15572509 |
73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.15231624 |
74 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14854311 |
75 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.13571313 |
76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10031057 |
77 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.09768013 |
78 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08601917 |
79 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.06134668 |
80 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.03659025 |
81 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.02753181 |
82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01575290 |
83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01563478 |
84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00414301 |
85 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98911563 |
86 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.97895745 |
87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97237573 |
88 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.95236635 |
89 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92795235 |
90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91695610 |
91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91555624 |
92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91555624 |
93 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.91147123 |
94 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.91101207 |
95 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.90173892 |
96 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89094521 |
97 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.88670495 |
98 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.88530061 |
99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87647824 |
100 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.87524528 |
101 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.86777521 |
102 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.85862997 |
103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.85735228 |
104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84752283 |
105 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84632378 |
106 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.84354770 |
107 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83637192 |
108 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.82740960 |
109 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.82195471 |
110 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.82170995 |
111 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.82170995 |
112 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81921800 |
113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81906725 |
114 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.81473535 |
115 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.81461501 |
116 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80929449 |
117 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.80808281 |
118 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80207807 |
119 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.78806330 |
120 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.78806330 |
121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78564108 |
122 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.78465990 |
123 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.77566513 |
124 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77199580 |
125 | GATA3_26560356_Chip-Seq_TH1_Human | 0.76463717 |
126 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.76154142 |
127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76115892 |
128 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.75743046 |
129 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.75534197 |
130 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75511938 |
131 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.75144246 |
132 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.75119249 |
133 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75096443 |
134 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.74831970 |
135 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.74481911 |
136 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.74478157 |
137 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71861442 |
138 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.71667134 |
139 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63666463 |
140 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63378585 |
141 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63227452 |
142 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.61808264 |
143 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61076506 |
144 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.60260125 |
145 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.59334775 |
146 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.59037054 |
147 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.57769372 |
148 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.57626381 |
149 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.56777392 |
150 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.56610949 |
151 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.56105396 |
152 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.54665709 |
153 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.52869134 |
154 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.52496005 |
155 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.52111012 |
156 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.51362400 |
157 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50357316 |
158 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.49862266 |
159 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.49583260 |
160 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.49552648 |
161 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.48954507 |
162 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47766282 |
163 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.47383607 |
164 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.46841828 |
165 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.45601451 |
166 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.45337495 |
167 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.44218495 |
168 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.43631338 |
169 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.43134517 |
170 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41716213 |
171 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.41395735 |
172 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.41044057 |
173 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.40481958 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.26972296 |
2 | MP0005360_urolithiasis | 7.00302266 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.92568185 |
4 | MP0008875_abnormal_xenobiotic_pharmacok | 5.81808971 |
5 | MP0005365_abnormal_bile_salt | 5.75439340 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.09055707 |
7 | MP0005671_abnormal_response_to | 3.69633739 |
8 | MP0003252_abnormal_bile_duct | 3.51086136 |
9 | MP0010329_abnormal_lipoprotein_level | 3.40482811 |
10 | MP0009840_abnormal_foam_cell | 3.20051372 |
11 | MP0001835_abnormal_antigen_presentation | 2.68361191 |
12 | MP0005332_abnormal_amino_acid | 2.67089732 |
13 | MP0005083_abnormal_biliary_tract | 2.62071202 |
14 | MP0009785_altered_susceptibility_to | 2.60310414 |
15 | MP0001666_abnormal_nutrient_absorption | 2.51412861 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.46196412 |
17 | MP0003195_calcinosis | 2.45743955 |
18 | MP0005058_abnormal_lysosome_morphology | 2.41887450 |
19 | MP0002148_abnormal_hypersensitivity_rea | 2.38113779 |
20 | MP0003186_abnormal_redox_activity | 2.32635713 |
21 | MP0003191_abnormal_cellular_cholesterol | 2.20555709 |
22 | MP0009333_abnormal_splenocyte_physiolog | 2.16017554 |
23 | MP0005025_abnormal_response_to | 2.10398925 |
24 | MP0001790_abnormal_immune_system | 2.09424493 |
25 | MP0005387_immune_system_phenotype | 2.09424493 |
26 | MP0005000_abnormal_immune_tolerance | 1.97109682 |
27 | MP0001800_abnormal_humoral_immune | 1.90539618 |
28 | MP0000609_abnormal_liver_physiology | 1.89014344 |
29 | MP0002118_abnormal_lipid_homeostasis | 1.86093940 |
30 | MP0002419_abnormal_innate_immunity | 1.81155306 |
31 | MP0002723_abnormal_immune_serum | 1.79489471 |
32 | MP0005319_abnormal_enzyme/_coenzyme | 1.76680902 |
33 | MP0002452_abnormal_antigen_presenting | 1.67599051 |
34 | MP0010155_abnormal_intestine_physiology | 1.66747576 |
35 | MP0002138_abnormal_hepatobiliary_system | 1.65310740 |
36 | MP0001845_abnormal_inflammatory_respons | 1.64194343 |
37 | MP0000685_abnormal_immune_system | 1.61335710 |
38 | MP0001764_abnormal_homeostasis | 1.56064052 |
39 | MP0003183_abnormal_peptide_metabolism | 1.53931033 |
40 | MP0001853_heart_inflammation | 1.53069039 |
41 | MP0003866_abnormal_defecation | 1.51138355 |
42 | MP0002420_abnormal_adaptive_immunity | 1.51043342 |
43 | MP0001819_abnormal_immune_cell | 1.50317052 |
44 | MP0009643_abnormal_urine_homeostasis | 1.45176560 |
45 | MP0003172_abnormal_lysosome_physiology | 1.42909235 |
46 | MP0009697_abnormal_copulation | 1.41707099 |
47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41502337 |
48 | MP0008789_abnormal_olfactory_epithelium | 1.39871515 |
49 | MP0000343_altered_response_to | 1.36995986 |
50 | MP0005394_taste/olfaction_phenotype | 1.34647913 |
51 | MP0005499_abnormal_olfactory_system | 1.34647913 |
52 | MP0005451_abnormal_body_composition | 1.34451557 |
53 | MP0008004_abnormal_stomach_pH | 1.32827342 |
54 | MP0004147_increased_porphyrin_level | 1.32327045 |
55 | MP0002405_respiratory_system_inflammati | 1.31144284 |
56 | MP0002254_reproductive_system_inflammat | 1.29417208 |
57 | MP0003763_abnormal_thymus_physiology | 1.27624901 |
58 | MP0001533_abnormal_skeleton_physiology | 1.26087692 |
59 | MP0000372_irregular_coat_pigmentation | 1.25536501 |
60 | MP0005408_hypopigmentation | 1.23303670 |
61 | MP0003868_abnormal_feces_composition | 1.22595079 |
62 | MP0010368_abnormal_lymphatic_system | 1.21445250 |
63 | MP0002837_dystrophic_cardiac_calcinosis | 1.20277621 |
64 | MP0001873_stomach_inflammation | 1.19748357 |
65 | MP0002277_abnormal_respiratory_mucosa | 1.19418393 |
66 | MP0005647_abnormal_sex_gland | 1.17860998 |
67 | MP0000716_abnormal_immune_system | 1.15426685 |
68 | MP0003705_abnormal_hypodermis_morpholog | 1.14903362 |
69 | MP0008995_early_reproductive_senescence | 1.11049876 |
70 | MP0005310_abnormal_salivary_gland | 1.10664395 |
71 | MP0000689_abnormal_spleen_morphology | 1.06778202 |
72 | MP0000598_abnormal_liver_morphology | 1.04347981 |
73 | MP0001984_abnormal_olfaction | 1.03920999 |
74 | MP0004043_abnormal_pH_regulation | 1.02831360 |
75 | MP0003656_abnormal_erythrocyte_physiolo | 1.01233039 |
76 | MP0002998_abnormal_bone_remodeling | 0.99785902 |
77 | MP0003011_delayed_dark_adaptation | 0.98965047 |
78 | MP0000371_diluted_coat_color | 0.98716359 |
79 | MP0009764_decreased_sensitivity_to | 0.98198423 |
80 | MP0005636_abnormal_mineral_homeostasis | 0.97519770 |
81 | MP0002398_abnormal_bone_marrow | 0.97022032 |
82 | MP0009763_increased_sensitivity_to | 0.95877873 |
83 | MP0002429_abnormal_blood_cell | 0.94951466 |
84 | MP0003303_peritoneal_inflammation | 0.93379057 |
85 | MP0005670_abnormal_white_adipose | 0.91014691 |
86 | MP0009053_abnormal_anal_canal | 0.90871030 |
87 | MP0005084_abnormal_gallbladder_morpholo | 0.89976325 |
88 | MP0001663_abnormal_digestive_system | 0.89732719 |
89 | MP0003300_gastrointestinal_ulcer | 0.89405997 |
90 | MP0010030_abnormal_orbit_morphology | 0.88813190 |
91 | MP0002722_abnormal_immune_system | 0.88580038 |
92 | MP0005266_abnormal_metabolism | 0.85590296 |
93 | MP0001756_abnormal_urination | 0.84744522 |
94 | MP0005167_abnormal_blood-brain_barrier | 0.83542770 |
95 | MP0005376_homeostasis/metabolism_phenot | 0.82857934 |
96 | MP0008469_abnormal_protein_level | 0.78667911 |
97 | MP0009642_abnormal_blood_homeostasis | 0.78223092 |
98 | MP0002876_abnormal_thyroid_physiology | 0.77225205 |
99 | MP0002132_abnormal_respiratory_system | 0.76770257 |
100 | MP0005174_abnormal_tail_pigmentation | 0.76443417 |
101 | MP0003690_abnormal_glial_cell | 0.75319019 |
102 | MP0001986_abnormal_taste_sensitivity | 0.75142519 |
103 | MP0009765_abnormal_xenobiotic_induced | 0.74970745 |
104 | MP0000604_amyloidosis | 0.74180645 |
105 | MP0002933_joint_inflammation | 0.73587839 |
106 | MP0003638_abnormal_response/metabolism_ | 0.72572323 |
107 | MP0002136_abnormal_kidney_physiology | 0.70503925 |
108 | MP0008872_abnormal_physiological_respon | 0.70401891 |
109 | MP0002971_abnormal_brown_adipose | 0.69601352 |
110 | MP0005075_abnormal_melanosome_morpholog | 0.69196822 |
111 | MP0005248_abnormal_Harderian_gland | 0.68673172 |
112 | MP0006036_abnormal_mitochondrial_physio | 0.68569090 |
113 | MP0000858_altered_metastatic_potential | 0.68143622 |
114 | MP0004947_skin_inflammation | 0.67500654 |
115 | MP0005334_abnormal_fat_pad | 0.67476704 |
116 | MP0004264_abnormal_extraembryonic_tissu | 0.67459970 |
117 | MP0004782_abnormal_surfactant_physiolog | 0.64446910 |
118 | MP0003718_maternal_effect | 0.63257750 |
119 | MP0005535_abnormal_body_temperature | 0.63213170 |
120 | MP0002078_abnormal_glucose_homeostasis | 0.61026997 |
121 | MP0006082_CNS_inflammation | 0.58198066 |
122 | MP0005377_hearing/vestibular/ear_phenot | 0.57993454 |
123 | MP0003878_abnormal_ear_physiology | 0.57993454 |
124 | MP0002928_abnormal_bile_duct | 0.56414628 |
125 | MP0003724_increased_susceptibility_to | 0.56236491 |
126 | MP0005395_other_phenotype | 0.54347332 |
127 | MP0009115_abnormal_fat_cell | 0.52613479 |
128 | MP0003453_abnormal_keratinocyte_physiol | 0.51958246 |
129 | MP0001346_abnormal_lacrimal_gland | 0.50996066 |
130 | MP0003436_decreased_susceptibility_to | 0.49642211 |
131 | MP0005220_abnormal_exocrine_pancreas | 0.49129726 |
132 | MP0003075_altered_response_to | 0.46434141 |
133 | MP0004130_abnormal_muscle_cell | 0.46117810 |
134 | MP0002877_abnormal_melanocyte_morpholog | 0.46039080 |
135 | MP0005166_decreased_susceptibility_to | 0.45340503 |
136 | MP0005023_abnormal_wound_healing | 0.45043899 |
137 | MP0004883_abnormal_blood_vessel | 0.43786672 |
138 | MP0005464_abnormal_platelet_physiology | 0.43212957 |
139 | MP0005164_abnormal_response_to | 0.41971286 |
140 | MP0002295_abnormal_pulmonary_circulatio | 0.41003060 |
141 | MP0000678_abnormal_parathyroid_gland | 0.40988628 |
142 | MP0000566_synostosis | 0.39466466 |
143 | MP0005666_abnormal_adipose_tissue | 0.39437694 |
144 | MP0010234_abnormal_vibrissa_follicle | 0.37792051 |
145 | MP0002249_abnormal_larynx_morphology | 0.37081943 |
146 | MP0002060_abnormal_skin_morphology | 0.36996026 |
147 | MP0005448_abnormal_energy_balance | 0.36935128 |
148 | MP0000613_abnormal_salivary_gland | 0.36799812 |
149 | MP0003953_abnormal_hormone_level | 0.36671944 |
150 | MP0008873_increased_physiological_sensi | 0.35750949 |
151 | MP0001881_abnormal_mammary_gland | 0.35450324 |
152 | MP0002135_abnormal_kidney_morphology | 0.34600244 |
153 | MP0002098_abnormal_vibrissa_morphology | 0.34350416 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 6.64023569 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.58761552 |
3 | Deep venous thrombosis (HP:0002625) | 6.56691073 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.23666303 |
5 | Hypobetalipoproteinemia (HP:0003563) | 5.81995682 |
6 | Xanthomatosis (HP:0000991) | 5.66029660 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.55869690 |
8 | Hyperglycinuria (HP:0003108) | 4.60800078 |
9 | Hyperlipoproteinemia (HP:0010980) | 4.58412096 |
10 | Complement deficiency (HP:0004431) | 4.54935912 |
11 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.54612532 |
12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.54612532 |
13 | Abnormality of glycolipid metabolism (HP:0010969) | 4.54612532 |
14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.48665181 |
15 | Hypolipoproteinemia (HP:0010981) | 4.42540395 |
16 | Hyperammonemia (HP:0001987) | 4.37398476 |
17 | Vacuolated lymphocytes (HP:0001922) | 4.33492675 |
18 | Hyperglycinemia (HP:0002154) | 4.26754405 |
19 | Fat malabsorption (HP:0002630) | 4.23637716 |
20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.19815113 |
21 | Abnormality of glycine metabolism (HP:0010895) | 4.19815113 |
22 | Ketosis (HP:0001946) | 4.16000878 |
23 | Conjugated hyperbilirubinemia (HP:0002908) | 4.11645535 |
24 | Joint hemorrhage (HP:0005261) | 4.11284018 |
25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.07259678 |
26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.03928331 |
27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.99502051 |
28 | Epidermoid cyst (HP:0200040) | 3.98926977 |
29 | Hypoalphalipoproteinemia (HP:0003233) | 3.85669746 |
30 | Abnormality of methionine metabolism (HP:0010901) | 3.81945852 |
31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.79504838 |
32 | Abnormality of the common coagulation pathway (HP:0010990) | 3.75804985 |
33 | Abnormality of macrophages (HP:0004311) | 3.71804188 |
34 | Hypoglycemic coma (HP:0001325) | 3.68814348 |
35 | Hypercholesterolemia (HP:0003124) | 3.52851126 |
36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.45795521 |
37 | Abnormality of complement system (HP:0005339) | 3.42780490 |
38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34144531 |
39 | T lymphocytopenia (HP:0005403) | 3.26371214 |
40 | Ketoacidosis (HP:0001993) | 3.26334443 |
41 | Steatorrhea (HP:0002570) | 3.24509516 |
42 | Abnormality of T cell number (HP:0011839) | 3.23296629 |
43 | Hyperbilirubinemia (HP:0002904) | 3.21702928 |
44 | Purpura (HP:0000979) | 3.21223445 |
45 | Abnormality of the intrinsic pathway (HP:0010989) | 3.20559739 |
46 | Abnormality of nucleobase metabolism (HP:0010932) | 3.18724864 |
47 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.08209559 |
48 | Hepatocellular carcinoma (HP:0001402) | 3.05881012 |
49 | Abnormality of purine metabolism (HP:0004352) | 3.05189535 |
50 | Myocardial infarction (HP:0001658) | 2.99038238 |
51 | Petechiae (HP:0000967) | 2.96145614 |
52 | Abnormality of serum amino acid levels (HP:0003112) | 2.93543605 |
53 | Metabolic acidosis (HP:0001942) | 2.91665008 |
54 | Autoimmune hemolytic anemia (HP:0001890) | 2.90438216 |
55 | Delayed CNS myelination (HP:0002188) | 2.86192150 |
56 | Chronic diarrhea (HP:0002028) | 2.84698456 |
57 | Gout (HP:0001997) | 2.84302193 |
58 | Eczematoid dermatitis (HP:0000976) | 2.82805249 |
59 | Joint swelling (HP:0001386) | 2.81683188 |
60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.76481215 |
61 | Dicarboxylic aciduria (HP:0003215) | 2.76481215 |
62 | Systemic lupus erythematosus (HP:0002725) | 2.73895310 |
63 | Abnormality of T cells (HP:0002843) | 2.71084490 |
64 | Abnormality of alanine metabolism (HP:0010916) | 2.70383542 |
65 | Hyperalaninemia (HP:0003348) | 2.70383542 |
66 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.70383542 |
67 | Lethargy (HP:0001254) | 2.69784040 |
68 | Generalized aminoaciduria (HP:0002909) | 2.68086178 |
69 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.65532204 |
70 | Recurrent cutaneous fungal infections (HP:0011370) | 2.65532204 |
71 | Stomatitis (HP:0010280) | 2.64733638 |
72 | Vascular calcification (HP:0004934) | 2.62007223 |
73 | Increased cerebral lipofuscin (HP:0011813) | 2.57059046 |
74 | Malnutrition (HP:0004395) | 2.56432433 |
75 | Proximal tubulopathy (HP:0000114) | 2.56131335 |
76 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.52274688 |
77 | Dysostosis multiplex (HP:0000943) | 2.51182918 |
78 | Recurrent abscess formation (HP:0002722) | 2.49688472 |
79 | Spastic diplegia (HP:0001264) | 2.47360151 |
80 | Esophageal varix (HP:0002040) | 2.45471715 |
81 | Spontaneous abortion (HP:0005268) | 2.43629964 |
82 | Congenital sensorineural hearing impairment (HP:0008527) | 2.42675584 |
83 | Optic neuritis (HP:0100653) | 2.37257769 |
84 | Retrobulbar optic neuritis (HP:0100654) | 2.37257769 |
85 | Autoimmune thrombocytopenia (HP:0001973) | 2.35753748 |
86 | Recurrent bacterial skin infections (HP:0005406) | 2.35121378 |
87 | Abnormality of proline metabolism (HP:0010907) | 2.35051592 |
88 | Hydroxyprolinuria (HP:0003080) | 2.35051592 |
89 | Pulmonary embolism (HP:0002204) | 2.33850468 |
90 | Recurrent fungal infections (HP:0002841) | 2.33126571 |
91 | Increased serum pyruvate (HP:0003542) | 2.33118382 |
92 | Hypochromic microcytic anemia (HP:0004840) | 2.32484184 |
93 | Renal cortical cysts (HP:0000803) | 2.32346110 |
94 | Pulmonary infiltrates (HP:0002113) | 2.31479420 |
95 | Cardiovascular calcification (HP:0011915) | 2.31438294 |
96 | Renal tubular acidosis (HP:0001947) | 2.30436717 |
97 | Increased IgM level (HP:0003496) | 2.29895200 |
98 | Myositis (HP:0100614) | 2.29761144 |
99 | Pancreatitis (HP:0001733) | 2.29056536 |
100 | Acanthocytosis (HP:0001927) | 2.26658329 |
101 | Recurrent skin infections (HP:0001581) | 2.25524920 |
102 | IgG deficiency (HP:0004315) | 2.22220715 |
103 | Abnormality of urine glucose concentration (HP:0011016) | 2.20925593 |
104 | Glycosuria (HP:0003076) | 2.20925593 |
105 | Irritability (HP:0000737) | 2.20442827 |
106 | Anorexia (HP:0002039) | 2.19656424 |
107 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.19352453 |
108 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.19352453 |
109 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.19352453 |
110 | Sensorimotor neuropathy (HP:0007141) | 2.19147339 |
111 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.18854131 |
112 | Rickets (HP:0002748) | 2.18782347 |
113 | Orchitis (HP:0100796) | 2.17882021 |
114 | Vasculitis (HP:0002633) | 2.17570385 |
115 | Skin nodule (HP:0200036) | 2.17159986 |
116 | Spontaneous hematomas (HP:0007420) | 2.17075689 |
117 | Vomiting (HP:0002013) | 2.16238059 |
118 | Cerebral edema (HP:0002181) | 2.14781977 |
119 | Abnormal cartilage morphology (HP:0002763) | 2.13437284 |
120 | Abnormal gallbladder morphology (HP:0012437) | 2.12600295 |
121 | Hemoptysis (HP:0002105) | 2.12460363 |
122 | Alkalosis (HP:0001948) | 2.11993226 |
123 | Amyloidosis (HP:0011034) | 2.11701299 |
124 | Cholelithiasis (HP:0001081) | 2.08853859 |
125 | Hyperuricemia (HP:0002149) | 2.08825811 |
126 | Increased purine levels (HP:0004368) | 2.08825811 |
127 | Pustule (HP:0200039) | 2.08237700 |
128 | Encephalitis (HP:0002383) | 2.08094729 |
129 | Metaphyseal irregularity (HP:0003025) | 2.07802186 |
130 | Chronic obstructive pulmonary disease (HP:0006510) | 2.07688805 |
131 | Obstructive lung disease (HP:0006536) | 2.07688805 |
132 | Epistaxis (HP:0000421) | 2.07103509 |
133 | Mucopolysacchariduria (HP:0008155) | 2.05890952 |
134 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05890952 |
135 | Abnormality of glycolysis (HP:0004366) | 2.03837088 |
136 | Polyneuropathy (HP:0001271) | 2.03479250 |
137 | Neonatal onset (HP:0003623) | 2.03150740 |
138 | Abnormality of eosinophils (HP:0001879) | 2.02698065 |
139 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.01462791 |
140 | Opisthotonus (HP:0002179) | 2.00244664 |
141 | Abnormality of the prostate (HP:0008775) | 1.99649317 |
142 | Hypoglycemic seizures (HP:0002173) | 1.99515041 |
143 | Abnormality of vitamin metabolism (HP:0100508) | 1.98813583 |
144 | Nephritis (HP:0000123) | 1.98150484 |
145 | Abnormal tarsal ossification (HP:0008369) | 1.96044295 |
146 | Glomerulonephritis (HP:0000099) | 1.96042049 |
147 | Nausea (HP:0002018) | 1.95960389 |
148 | Increased serum ferritin (HP:0003281) | 1.95753997 |
149 | Aplastic anemia (HP:0001915) | 1.94911542 |
150 | Enlarged kidneys (HP:0000105) | 1.94154403 |
151 | Mitral stenosis (HP:0001718) | 1.93614920 |
152 | Thrombophlebitis (HP:0004418) | 1.93169209 |
153 | Pigmentary retinal degeneration (HP:0001146) | 1.92666853 |
154 | Disinhibition (HP:0000734) | 1.91145397 |
155 | Abnormal gallbladder physiology (HP:0012438) | 1.91118920 |
156 | Cholecystitis (HP:0001082) | 1.91118920 |
157 | Brushfield spots (HP:0001088) | 1.90156236 |
158 | Gingival bleeding (HP:0000225) | 1.89706818 |
159 | Meningitis (HP:0001287) | 1.89274544 |
160 | Ileus (HP:0002595) | 1.88839720 |
161 | Hypertriglyceridemia (HP:0002155) | 1.88801562 |
162 | Hepatosplenomegaly (HP:0001433) | 1.88454142 |
163 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88106164 |
164 | Abnormality of T cell physiology (HP:0011840) | 1.87651778 |
165 | Late onset (HP:0003584) | 1.86130740 |
166 | Polycythemia (HP:0001901) | 1.85995145 |
167 | Elevated hepatic transaminases (HP:0002910) | 1.84014662 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 6.69477513 |
2 | BCKDK | 6.17166830 |
3 | MAP4K1 | 4.10603198 |
4 | ACVR1B | 3.90497678 |
5 | ERN1 | 3.71133418 |
6 | FGFR4 | 3.52350291 |
7 | SIK1 | 3.00135219 |
8 | FRK | 2.86449522 |
9 | MAP3K3 | 2.59835058 |
10 | PBK | 2.39023809 |
11 | ERBB4 | 2.32724638 |
12 | PKN2 | 2.28572899 |
13 | MST1R | 2.14118693 |
14 | TRIB3 | 2.09386426 |
15 | MAP2K3 | 2.08860062 |
16 | ADRBK2 | 2.07284343 |
17 | RIPK4 | 2.04229065 |
18 | STK38L | 1.93953330 |
19 | TESK2 | 1.86056022 |
20 | INSRR | 1.81032252 |
21 | BLK | 1.78665001 |
22 | LATS1 | 1.75045815 |
23 | TAOK3 | 1.71609925 |
24 | MAPK15 | 1.59494764 |
25 | ITK | 1.58863840 |
26 | GRK7 | 1.58341987 |
27 | IRAK4 | 1.54298792 |
28 | ZAP70 | 1.52226867 |
29 | TAOK2 | 1.50671255 |
30 | TYK2 | 1.49854585 |
31 | RIPK1 | 1.43450973 |
32 | ZAK | 1.38383187 |
33 | MATK | 1.36795767 |
34 | MAP3K11 | 1.35677210 |
35 | EPHA3 | 1.35516861 |
36 | IRAK3 | 1.34512183 |
37 | NEK9 | 1.29789167 |
38 | MAPK11 | 1.29056009 |
39 | FGR | 1.25663921 |
40 | MST4 | 1.25522078 |
41 | MAP2K6 | 1.24114703 |
42 | EPHB1 | 1.23586745 |
43 | FLT3 | 1.22644748 |
44 | MAP2K2 | 1.17227636 |
45 | SYK | 1.14129752 |
46 | LYN | 1.13884548 |
47 | PTK6 | 1.13866050 |
48 | MAP3K14 | 1.13823407 |
49 | LCK | 1.13675425 |
50 | TBK1 | 1.11095329 |
51 | CAMKK2 | 1.08124933 |
52 | TAOK1 | 1.07896669 |
53 | ABL2 | 1.07638318 |
54 | PRKCQ | 1.07402799 |
55 | CDK6 | 1.06258223 |
56 | RPS6KB2 | 1.04035410 |
57 | MAP2K4 | 1.00905862 |
58 | PINK1 | 1.00547207 |
59 | EPHA2 | 0.97737100 |
60 | ERBB2 | 0.96398943 |
61 | FES | 0.96045995 |
62 | PRKAA2 | 0.95227760 |
63 | JAK2 | 0.94861637 |
64 | PIK3CG | 0.94405764 |
65 | NLK | 0.89521561 |
66 | MAP3K2 | 0.88374804 |
67 | JAK1 | 0.87026168 |
68 | GRK1 | 0.85927693 |
69 | SGK2 | 0.84989322 |
70 | TRIM28 | 0.83881607 |
71 | STK10 | 0.83806684 |
72 | MAP3K7 | 0.82146059 |
73 | SGK3 | 0.81372423 |
74 | TEC | 0.81279204 |
75 | IKBKE | 0.80796737 |
76 | CSF1R | 0.80741073 |
77 | MAPKAPK3 | 0.80224408 |
78 | GRK6 | 0.79436813 |
79 | TLK1 | 0.77003739 |
80 | MAP2K1 | 0.76798735 |
81 | BMPR1B | 0.75566916 |
82 | KDR | 0.74645432 |
83 | NUAK1 | 0.74468522 |
84 | BTK | 0.74393263 |
85 | STK4 | 0.72869470 |
86 | OXSR1 | 0.72150742 |
87 | MARK3 | 0.70948819 |
88 | KIT | 0.70020941 |
89 | PDK3 | 0.69910540 |
90 | PDK4 | 0.69910540 |
91 | EPHB2 | 0.67834330 |
92 | MAP3K5 | 0.67405407 |
93 | BMPR2 | 0.67261712 |
94 | HCK | 0.66173563 |
95 | MET | 0.65337624 |
96 | FGFR3 | 0.64888939 |
97 | NME2 | 0.61316901 |
98 | WNK4 | 0.60379617 |
99 | SGK223 | 0.60018902 |
100 | SGK494 | 0.60018902 |
101 | IGF1R | 0.59728740 |
102 | PDK2 | 0.58194302 |
103 | PAK3 | 0.56998573 |
104 | MAPK4 | 0.56664974 |
105 | GSK3A | 0.55935950 |
106 | WNK3 | 0.54601911 |
107 | MAP3K1 | 0.53308667 |
108 | EIF2AK1 | 0.52829230 |
109 | EIF2AK3 | 0.52458265 |
110 | AKT3 | 0.50059422 |
111 | LRRK2 | 0.49462177 |
112 | STK39 | 0.49273955 |
113 | LATS2 | 0.48924534 |
114 | PIK3CA | 0.48807026 |
115 | TRPM7 | 0.48776135 |
116 | PRKCZ | 0.48517073 |
117 | TIE1 | 0.47809554 |
118 | TGFBR2 | 0.47549262 |
119 | CHUK | 0.47308563 |
120 | TNIK | 0.46016458 |
121 | IRAK1 | 0.43887666 |
122 | TESK1 | 0.43865199 |
123 | CSK | 0.43497300 |
124 | FER | 0.42285205 |
125 | PRKAA1 | 0.41272498 |
126 | MYLK | 0.41250325 |
127 | JAK3 | 0.41217779 |
128 | PDPK1 | 0.40921915 |
129 | PRKG2 | 0.39483570 |
130 | TTK | 0.38864986 |
131 | STK3 | 0.38165739 |
132 | MAP3K6 | 0.37879394 |
133 | STK38 | 0.37287847 |
134 | PRKCD | 0.37147148 |
135 | LMTK2 | 0.36986372 |
136 | CAMK2G | 0.36727360 |
137 | CSNK2A1 | 0.36422556 |
138 | MAPK7 | 0.36199988 |
139 | PDK1 | 0.35695738 |
140 | PRKACG | 0.35505623 |
141 | CSNK1A1 | 0.34800946 |
142 | IKBKB | 0.34616360 |
143 | STK16 | 0.34468162 |
144 | ADRBK1 | 0.34184991 |
145 | MAPKAPK2 | 0.33536950 |
146 | PRKCA | 0.32714300 |
147 | FYN | 0.31832401 |
148 | MAP3K12 | 0.30408750 |
149 | MAP3K8 | 0.29608976 |
150 | VRK1 | 0.27968108 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 4.22173189 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.78799027 |
3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.62782377 |
4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.96127297 |
5 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.77190902 |
6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.76274367 |
7 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.63063734 |
8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.56291881 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.42017553 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37813048 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36243790 |
12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.34086560 |
13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27939067 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24992425 |
15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.23728688 |
16 | Other glycan degradation_Homo sapiens_hsa00511 | 2.18843995 |
17 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.16949975 |
18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.16764109 |
19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.16163970 |
20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.15540920 |
21 | Allograft rejection_Homo sapiens_hsa05330 | 2.14791404 |
22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.14346740 |
23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.14220126 |
24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.09493043 |
25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.07005216 |
26 | Peroxisome_Homo sapiens_hsa04146 | 2.05306759 |
27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.96859619 |
28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.94342565 |
29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89962195 |
30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.89610348 |
31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83931900 |
32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81616200 |
33 | Asthma_Homo sapiens_hsa05310 | 1.80036973 |
34 | Lysosome_Homo sapiens_hsa04142 | 1.77300254 |
35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75578828 |
36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.75522016 |
37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.67945467 |
38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59604498 |
39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59068921 |
40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.59020828 |
41 | Proteasome_Homo sapiens_hsa03050 | 1.56744888 |
42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.54656767 |
43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.54322357 |
44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.49336412 |
45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45157680 |
46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44874132 |
47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44122446 |
48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.42792425 |
49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38474120 |
50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.37804572 |
51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.35729337 |
52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.35151788 |
53 | Bile secretion_Homo sapiens_hsa04976 | 1.34524183 |
54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.33441196 |
55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31057732 |
56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29319328 |
57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28833047 |
58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27611973 |
59 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26460282 |
60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22446627 |
61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19364684 |
62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14356564 |
63 | ABC transporters_Homo sapiens_hsa02010 | 1.13306083 |
64 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04692944 |
65 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04218951 |
66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01973476 |
67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98285509 |
68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97900971 |
69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96871457 |
70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96434268 |
71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94832083 |
72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93900856 |
73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92519824 |
74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91144290 |
75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.88539401 |
76 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85951152 |
77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84990163 |
78 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82484862 |
79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80610611 |
80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.79765538 |
81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78729555 |
82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75263113 |
83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73099347 |
84 | Measles_Homo sapiens_hsa05162 | 0.68745349 |
85 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.68222456 |
86 | Lysine degradation_Homo sapiens_hsa00310 | 0.66365722 |
87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63265821 |
88 | Phagosome_Homo sapiens_hsa04145 | 0.61710244 |
89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61152531 |
90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59202649 |
91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58528331 |
92 | Tuberculosis_Homo sapiens_hsa05152 | 0.57666320 |
93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57506650 |
94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55310401 |
95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51649588 |
96 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50189462 |
97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50115707 |
98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50093678 |
99 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.43922236 |
100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42978700 |
101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37785372 |
102 | Prion diseases_Homo sapiens_hsa05020 | 0.36569394 |
103 | * Galactose metabolism_Homo sapiens_hsa00052 | 0.31102605 |
104 | Insulin resistance_Homo sapiens_hsa04931 | 0.20400522 |
105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20311461 |
106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16870848 |
107 | Mineral absorption_Homo sapiens_hsa04978 | 0.14336646 |
108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12102334 |
109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.07249629 |
110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03793285 |
111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.03784424 |
112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.00337872 |
113 | TNF signaling pathway_Homo sapiens_hsa04668 | -0.1870079 |
114 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1856350 |
115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.1784527 |
116 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1757881 |
117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1754971 |
118 | Legionellosis_Homo sapiens_hsa05134 | -0.1561903 |
119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1539440 |
120 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.1487719 |
121 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1307433 |
122 | Pertussis_Homo sapiens_hsa05133 | -0.1271553 |
123 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1209576 |
124 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1017860 |
125 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0872313 |
126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0867713 |
127 | Hepatitis C_Homo sapiens_hsa05160 | -0.0724641 |
128 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0715473 |
129 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0608372 |
130 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0254879 |
131 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0144513 |
132 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0134437 |